Enzychem Lifesciences Faces Temporary Injunction for Shareholder Status over 5.74% Stake, Signaling Potential Control Dispute
Applicant Lee Soo-min has filed a temporary injunction with the Seoul Central District Court to confirm shareholder status over 4,857,465 common shares of Enzychem Lifesciences valued at approximately 2.35 billion won, representing about 5.74% of total outstanding shares. This could be a prelude to a control dispute.
The company has appointed legal counsel and plans to argue at the hearing on July 6, 2026, that the applicant's shareholder status is not confirmed in official records, including the shareholder register and electronic registration.
The outcome of this injunction may affect obligations such as share registry updates, potentially increasing short-term stock price volatility. Future litigation could even lead to management changes.
[AI Summary]Enzychem Lifesciences faces a temporary shareholder status injunction over a 5.74% stake, introducing control dispute risk. Court decisions and the main lawsuit could significantly impact governance and shareholder value, warranting investor vigilance.
KOSDAQ Filing Information
Filing of Lawsuit, etc. (Management Dispute Lawsuit) (Provisional Disposition for Confirmation of Temporary Shareholder Status)